Journalist Hunt

Resources ▾

Journalist DatabaseFor JournalistsPricing
LoginSign up

Niko McCarty - Journalist Profile | Connect with top journalists

View 's journalist industries, journalist types, location, and media outlets. Use Journalist Hunt to get connected with top journalists in seconds.

Get connected with journalists today
Founding Editor, Asimov Press

Niko McCarty

Verified

Founding Editor, Asimov Press

Cambridge

Beats

Primary beats

Science

Secondary beats

Clinical PharmacologyHistorySpecialty ChemicalsBiotechnologyBioinformaticsTechnical LawEnvironmental ConservationSustainabilityScienceRheumatoid ArthritisPharmacokineticsParentingBooksEngineeringGeneralClimateStories About PeopleBeesPoliticEarth Sciences

Biography

Final Covers

Science media. health mental health technology

Doesn’t Cover

Oncology

Journalist Type

Founding Editor

Seniority Positions

Senior

Industries

Research

Medium Formats

Print,Digital

Content

Total articles 159

  • Available on paid plans

    The Most Abundant Protein

    By Niko McCarty

    Feb. 11, 2025

  • Available on paid plans

    The Cell is a Bag of Molecules

    By Niko McCarty

    Jan. 28, 2025

  • Available on paid plans

    The Most Abundant Protein

    By Niko McCarty

    Feb. 11, 2025

As seen in

Scientific American,Spectrum,The Startup,Substack,Earth Island Journal,Ai Supremacy,Asimov Press,Medium,Mercatus Center,Perishable News,Retraction Watch

Company Info

Asimov Press

Asimov is a biotechnology company founded in 2017 that focuses on integrating mammalian synthetic biology with computer-aided design to enhance therapeutic applications. The co-founders, including Alec Nielsen, Chris Voigt, and Doug Densmore, developed genetic logic circuit design tools during their time at MIT and Boston University. The company offers a variety of services and products centered around genetic design and cell engineering. Key offerings include genetic design tools for programming living cells, lentivirus production services to support cell and gene therapy development, and solutions for engineering mammalian systems for therapeutics, such as chimeric antigen receptor (CAR) therapies. Asimov's technology combines biological expertise with computational tools to streamline the design and production processes in the biotechnology sector.

Cambridge, , United Kingdom

+1 617-849-9299

Founded: 2017


Journalist Hunt

Email us

contact@journalisthunt.com
Terms and ConditionsRefund PolicyPrivacy Policy

Copywright © 2025, Journalist Hunt. All right reserved